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CHAPTER I 
 
INTRODUCTION 
 
Background and Research Objectives 
 
Significance   
The random nature of the B cell antigen diversification results in a substantial 
population of auto-reactive lymphocytes. To avoid autoimmunity, self-reactive B cell 
clones are eliminated by negative and positive selection during immature to mature B 
cell development. Although mutations in the B cell receptor (BCR) signaling components 
(e.g. Lyn, Syk, Btk, PLC-γ2, etc.)(2,8,11, 13-17) interrupt this transition; the molecular 
basis for this selection process remains unknown. The focus of these studies is to define 
the unique signaling molecules recruited to the BCR in transitional B cell subsets after 
BCR ligation and to characterize the gene expression profiles of T1 versus T2 B cell 
subsets as a means to determine whether stage specific BCR mediated outcomes in 
these B cell subsets are controlled by transcriptional and/or posttranslational 
modification of signaling proteins. Results from these studies will lead to the 
understanding of the mechanisms that drive negative versus positive selection 
processes of transitional B cells in the spleen.  
 
B Cell Development   
The production of functionally mature B lymphocytes requires the passage of 
precursor B cells through antigen-independent and antigen-dependent stages of 
development (Fig. 1).  Early B cell development in the bone marrow culminates in the 
expression of IgM molecules or B cell antigen receptors (BCRs) on the surface of the 
 1 
immature B cells (18, 19). Of the 10-20 million immature B cells (IgM+) produced daily in 
the bone marrow, only 10% reach the periphery; of these, only 10-30% joins the mature 
B cell pool.  Negative selection of self-reactive immature B cells can occur by multiple 
mechanisms, including deletion, anergy or receptor editing upon antigen encounter 
(22,31). Emigration of bone marrow derived immature B cells into the spleen as well as 
subsequent development into mature B cells is reliant upon successful cell surface 
expression of a functional BCR, as well as the functional biochemical signals emanating 
from the BCR. Targeted gene deletions of BCR signaling components (e.g. Lyn, Syk, Btk, 
PLC-γ2, etc.) interfere with the progression of immature to mature for maintenance of the 
mature B cell subsets (2,8,11, 13-17). Despite the requirement for BCR signaling during 
immature to mature B cell development, the specific roles and mechanisms for BCR 
signaling in this process remain poorly understood (21, 29-31). Previous studies have 
revealed that immature and mature B cell subpopulations display distinct responses to 
similar stimuli.  For example, in response to IgM crosslinking, immature B cells die 
whereas mature B cells proliferate (2).  Splenic immature B cells can be divided into at 
least two developmental subpopulations, Transitional type 1 (T1) and Transitional type 2 
(T2) B cells (8). I hypothesize that T1 B cells, the most recent emigrants from the BM, 
develop into T2 B cells, which in turn are thought to develop into mature follicular (Fo) 
and marginal zone (MZ) B cells (8, Fig. 1) We and others have shown that T1 cells die 
whereas T2 cell survive, proliferate, and display a mature B cell phenotype following 
BCR engagement (2, 8-11). These observations suggest that the BCR may deliver 
distinct stage-specific signals within the immature B cell subsets that result in biologically 
distinct outcomes which in turn are indispensable for the generation of non-autoreactive 
mature B lymphocytes. However, the nature of these stage-specific signals is not 
completely understood. 
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Figure 1. A Model for Splenic B cell Development. 
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BCR signaling and the BCR Signalosome  
The BCR is a multi-protein receptor containing membrane immunoglobulin 
(mIgM), composed of a heavy and light chain that form the antigen binding pocket. The 
mIgM is associated with signal transducing chains Igα and Igβ (CD79a and CD79b), 
both of which contain one immunoreceptor tyrosine activation motif (ITAM) in their 
cytoplasmic tail (35, 36). The first membrane proximal event after BCR aggregation is 
activation of the Src family kinase Lyn, which is constitutively associated with lipid 
microdomains. Activated Lyn then phosphorylates ITAMs within the Igα and Igβ chains. 
In turn, the tyrosine phosphorylated ITAMs propagate signals via the recruitment and 
activation of cytoplasmic protein tyrosine kinases (PTKs) including Syk, Bruton’s tyrosine 
kinase (Btk), Fyn and Blk (35). These kinases initiate the downstream signaling events 
that recruit adapter proteins BLNK (B cell linker protein), Grb2, guanine exchange 
factors (Vav1/2/3) and lipid metabolizers, PI3K (phosphatidylinositol 3 kinase) and PLC-
γ2. Activation of PLC-γ2 results in the hydrolysis of phosphatidyl inositol 4,5 biphosphate 
(PIP2) to the lipid second messenger’s diacylglycerol (DAG), which activates the 
serine/threonine kinase PKC, and inositol 3,4,5, triphosphate (IP3), which regulates 
intracellular calcium fluxes from endoplasmic reticulum. Together these molecules 
contribute to the formation of a large protein complex termed the BCR signalosome (15, 
25, 28, 39). The biological significance of many of these signaling proteins including BTK, 
PLC-γ2 and PI3K in T2 to mature B cell transition have been demonstrated (3, 25, 28).   
Most of these, with the exception of Syk and Lyn appear to be dispensable for T1 to T2 
cell development.  This could either suggest that, signaling in T1 cells is quantitatively 
different from T2 cells and/or that the biochemical signals discharged from the BCR in 
T1 versus T2 cells are coupled differentially to the downstream effectors by the presence 
or absence of distinct components of the BCR signalosomes in the two B cell subsets.   
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Lipid Rafts and BCR Signaling  
  Current studies clearly establish that multiple signaling pathways operate in BCR 
mediated B cell survival and development. However, the mechanisms utilized by these 
signaling pathways in specific transitional B cell subsets remain undefined. One 
mechanism involves recruitment of the BCR and signaling proteins to the plasma 
membrane. The segregation of proteins and lipids in the plasma membrane is a key 
feature of antigen receptor signal transduction. Ordered membrane domains, termed 
lipid rafts, contain sphingolipids such as sphingomyelin, ganglioside GM1 and 
cholesterol  (40, 41). Lipid rafts may serve as signal transduction platforms for the 
assembly of BCR signaling proteins (10, 41, 42,43). In resting cells the BCR is excluded 
from lipid rafts. Upon antigen encounter or BCR cross-linking, the receptor translocates 
into lipid rafts where the signal transducing molecules Igα and Igβ are phosphorylated by 
Lyn, which is constitutively associated with lipid rafts. In turn, recruitment of various 
signaling proteins responsible for the propagation of downstream signaling also takes 
place in lipid rafts. As such, recent studies have used membrane fractionation to identify 
signaling proteins in lipid rafts or confocal microscopy to show direct evidence of co-
localization of the BCR with signaling proteins (40-43).   
 
BCR Signaling NF-κB and Survival Genes 
One of the main downstream targets of BCR signaling is the activation of a family 
of transcription factors known as NF-κB. NF-κB regulates survival, development and B 
cell activation. Upon activation of B cells by BCR engagement, dimeric NF-κB 
transcription factors translocate to the nucleus and regulate the expression of multiple 
cellular genes. There are two pathways that activate NF-κB, one is known as the 
classical pathway and the other is the alternative pathway. These pathways target five 
NF-κB subunits, which include c-Rel, RelA (p65), RelB, NF-κB1 (p105/p50) and NF-κB2 
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(p100/p52). The alternative pathway targets p100 by inducing its phosphorylation and 
leads to it’s processing into p52. The classical pathway targets p50: RelA, p50: c-Rel or 
homodimers of these subunits. The activity of NF-κB through the classical pathway is 
primarily regulated by interactions with inhibitory IκB proteins. There are several IκB 
proteins, these include, IκBα, IκBβ, IκBγ, IκBε and IκBζ. This interaction blocks the 
ability of NF-κB to bind to DNA and results in the NF-κB complex being primarily in the 
cytoplasm due to a strong nuclear export signal in IκBs. It is known that BCR 
engagement only targets the classical pathway (3). BCR signals that lead to activation of 
NF-κB converge on the activation of a high molecular weight complex that contains 
serine-specific IκB kinases (IKKs).  Lymphocytes contain at least three major distinct 
subunits:  IKKα, IKKβ and IKKγ.   In the classical pathway, activation of the IKK complex 
leads to the phosphorylation by IKKβ of IκBα, which targets IκBα for ubiquitination and 
degradation by the 26S proteasome allowing the unbound NF-κB to translocate into the 
nucleus. There are many families of anti- and pro-apoptotic genes. One of the better 
characterized is the Bcl-2 family, which is known to be a target of NF-κB. The relative 
expression and activity of various anti-apoptotic and pro-apoptotic Bcl-2 family proteins 
is a critical determinant of apoptosis sensitivity. Precisely how the functions of the 
separate subfamilies and individual Bcl-2 proteins are coordinated to control apoptosis is 
unclear. 
Because one of the major differences between T1 and T2 B cells is their 
differential sensitivity to apoptosis, the studies in my thesis are particularly focused on 
determining stage specific expression of anti- and pro apoptotic genes and the 
components of the NF-κB signaling pathway. 
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CHAPTER II 
 
PROTEOMIC ANALYSIS OF BCR SIGNALOSOMES IN T1, T2 AND MATURE B 
CELLS 
 
Abstract 
Our lab has shown that relative to T1, T2 cells more robustly activate certain 
signaling pathways under BCR control such as PLC-γ2/DAG, Ras/ERK and PI3K/Akt. 
These data suggest that T1 cells activate different signaling pathways compared to T2 
cells.  I hypothesize that BCR engagement recruits distinct signalosomes in T1 versus 
T2 B cells and leads to disparate biological responses in the two subsets. To test this 
hypothesis, I have investigated the composition of the BCR signalosomes recruited to 
lipid rafts isolated from T1, T2 and mature B cells using immunoblotting and mass 
spectrometric analyses. These studies identified the serine/threonine phosphatase PP2A, 
the CD45 associated protein (CD45-AP), and a never before identified protein in B cells, 
Src Kinase Associated Phosphoprotein (SKAP55). These molecules were identified 
selectively in lipid rafts isolated from T1 cells by a proteomics approach. I employed 
conventional biochemical analysis to verify these results with the longterm goal of 
defining the function of these proteins in peripheral B cell differentiation. 
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Introduction 
Our current model to explain the disparate biological outcomes in T1 and T2 B 
cells is that differences in the composition of the BCR signalosomes activate distinct 
downstream signaling pathways and their target genes. Our lab has shown that T2 cells 
robustly induce the phosphorylation of ERK 1/2 and AKT in comparison to T1 cells. My 
long-term goal is to understand the molecular mechanisms controlling signal-induced 
apoptosis in T1 B cells and survival and differentiation in T2 B cells. The specific nature 
of these different BCR signaling mechanisms remains uncharacterized. Preliminary 
results demonstrating that T1 and T2 B cell populations respond distinctly to BCR 
engagement (Fig. 1)(2), support my hypothesis that the distinct biological outcomes 
following BCR signaling in T1 versus T2 cells results from alterations in the composition 
of the BCR signalosome. Activation of BCR induced signaling occurs primarily by 
protein-protein interactions and their membrane localization in proximity of the BCR and 
their substrates. One major mechanism of BCR signaling involves recruitment of BCR 
and the signaling proteins into detergent resistant membrane microdomians or lipid rafts 
(40-42). Therefore, I have examined the BCR signaling proteins that are recruited to lipid 
rafts in response to BCR crosslinking in transitional and mature B cell subsets. 
 
Materials and methods 
 
Mice 
Dr. A. Takeda from Northwestern University graciously provided CD45-AP-/- mice. 
Cells used for B cell purification of subsets were from C57Bl6 mice. All mice that were 
used as the source of splenocytes were treated humanely in accordance with federal 
and state government guidelines, and their use was approved by the Institutional Animal 
Care and Use Committee (Vanderbilt University). 
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 Cells and Isolation of Pure T1, T2 and Mature B cells 
Primary B lymphocytes were isolated from spleens of C57Bl6 mice and purified by 
AutoMACS (Miltenyi Biotec) by a negative selection protocol as described previously (29, 
30). The purity of B cells isolated in this manner was approximately 90–95% as verified 
by FACS analysis using anti-B220 and anti-IgM antibodies (Pharmingen, USA). To 
further separate the cells into purified subsets, Total splenocytes were stained using 
magnetic beads labeled with anti- AA4.1 and positively selected by AutoMACS (Miltentyi 
Biotech.) AA4.1 positive cells were then stained with FITC-conjugated anti-HSA (CD24), 
and biotinylated anti-CD23 (revealed by Cy-chrome-labeled streptavidin) antibodies to 
sort T1 (CD23low/- HSAhi) and T2 (CD23Hi HSAhi). Cells were sorted on a FACStarTM 
fluorescent cell sorter (Becton Dickenson). Re-analysis of the sorted B cell subsets by 
FCM revealed high purity for T1 (94%); T2 (77%) (Fig. 2) and mature (96.5%, data not 
shown) B cells. Mature B cells were sorted by CD43 depletion as described previously of 
the AA4.1 negative fraction, followed by an additional CD23 depletion by AutoMACS 
(Miltenyi Biotec) by a negative selection to remove and MZ B cells. Anti-IgM was not 
used for sorting to prevent inadvertent triggering of BCR signals. This protocol for B cell 
purification yields sufficient numbers of transitional and mature B cells to perform multiple 
functional and biochemical experiments described in the following sections. We routinely 
obtain ~1x107 T1 and 1-2x107 T2 B cells by FACS sorting. 
 
Lipid Raft Isolation 
Primary B-lymphocytes or purified T1, T2 and mature cells were stimulated with 
20 µg/ml of anti-IgM (Jackson Laboratories) for 5 min or left unstimulated. Lysates from 
2.5-5x106 cells were prepared in a non-ionic lysis buffer (Tris-HCl: 10 mM, pH 7.5, NaCl: 
150 mM, Triton X-100: 1%, EDTA: 5 mM, PMSF: 1 mM, Aprotinin 1 µg/ml, Na3VO4:         
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Figure  2. Purification of T1, T2 and M B cell populations. Splenocytes from 4 week 
old C57BL/6 nice were depleted of red blood cells and stained using anti-AA4.1, anti-
CD23, and anti-HSA. The left top panel depicts the sorting gates used to fractionate 
AA4.1 positive from AA4.1 negative cells. The proportion of total cells analyzed within the 
gates is indicated. Only live cells were sorted. The upper left plot shows the gates used to 
sort T1 and T2 cells based on CD23 expression. The lower 2 plots depict re-analysis of 
the indicated sorted cell population, with the fraction of all cells that fall within each 
quadrant as indicated. 
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1 mM, NaF: 1 mM) for 10 min at 4ºC in 50 µl. Lysates were centrifuged at maximum 
speed for 10 min to remove cellular debris. The gradient was prepared with Optiprep/ 
Iodixanol (Nycomed through Pharmacia), which comes as a 60% solution and formed in 
a 2 ml Sorvall tube. To make the gradient, I prepared a 40% solution of Optiprep,1% TX-
100 and a 5% solution of Optiprep, 1% TX-100. Lysates (50 µl) were mixed with 250 µl 
of 60% optiprep, 1% TX-100 to end up with a final volume of 300 µl of 50% optiprep in 
the Sorvall centrifuge tube. Next, 1.6 ml of 40% optiprep/TX-100 was layered on the 
50% and finally 100 µl of the 5% was layered. The tubes were spun in an ultracentrifuge 
in an RP55A rotor at 55,000 RPM for 3 hours at 4ºC (Fig. 3A). Once centrifuged, 200 µl 
fractions were collected from each sample and subjected to SDS-PAGE or TCA 
precipitated to be submitted for proteomic analysis. 
 
Western Blot Analysis 
For raft recruitment studies approximately 10% (20 µl) of the isolated fractions in 
Iodixanol were resolved by 8-10% SDS–PAGE, and transferred on to Immobilon (PVDF, 
Millipore) membranes. The membranes were then blocked and subsequently probed in 
solutions containing 1x TBST (Tris-buffered saline and 0.1% Tween) and 5% nonfat dry 
milk or 3% BSA (Bovine Serum Albumin). The blots were probed with polyclonal 
antibodies for PKC-βII, PLC-γ2, Lyn and Bcl-2 (Santa Cruz). The PP2AC monoclonal 
antibody was from BD Transduction Laboratories and Syk from Cell Signaling 
Technology. The bound antibodies were revealed by horseradish peroxidase-conjugated 
goat anti-rabbit, or anti-mouse antibodies (Pierce) and detected by enhanced 
chemiluminescent detection (Pierce) on autoradiography film. 
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Immunoprecipations  
Primary B lymphocyte lysates from 11x106 cell were prepared in RIPA buffer 
(Tris-HCl: 50 mM, pH 7.4, NaCl: 150 mM, Triton X-100: 1%, SDS: 0.1%, EDTA: 1 mM, 
PMSF: 1 mM, Aprotinin 1 µg/ml, Na3VO4: 1 mM, NaF: 1 mM) for 10 min at 4ºC. Cell 
lysates were pre-cleared by incubating with either protein A-Sepharose or G-Sepharose 
beads for 1 h at 4ºC. The beads were pelleted and cellular extracts removed. Cell 
extracts were incubated with 2 µg of the PP2Ac monoclonal antibody (Transduction Lab) 
and protein G-Sepharose or with 2µg of the IKKγ polyclonal antibody (FL-419, Santa 
Cruz) and protein A-Sepharose for 12-14 h at 4ºC. Cell extracts were also incubated 
with the corresponding IgG as controls. The beads were pelleted and washed 3 times 
with ELB buffer. Bound proteins were eluted with SDS sample buffer and subjected to 
immunoblot analysis by SDS-PAGE. 
 
Semiquantitative RT-PCR 
 100 ng of total RNA from FACS purified T1, T2 and mature B cells was subjected 
to semi-quantitative RT-PCR to detect transcript levels of SKAP55. RNA from T cells 
was used as a positive control. The amplified products were analyzed by TBE-
polyacrylamide gel followed by ethidium bromide stain. GAPDH was used as a 
housekeeping gene. The conditions and primer sequences used were: 
SKAP55 5’ primer: TTGCAGAATGAGAACCTCAGCCCT 
SKAP55 3’ primer: CCCTCGTCCTGATAATCTGACCAA 
GAPDH 5’ primer: AACGACCCCTTCATTGAC 
GAPDH 3’ primer: TCCACGACATACTCAGCAC 
94ºC 5’  1 cycle  
94ºC 30’’ 
60ºC 30’’ 32 cycles 
72ºC 1’ 
72ºC 7’           1 cycle 
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Mass Spectrometric Analysis 
MS analysis of lipid rafts was performed as previously described (48). 
 
 
Results 
  
Microscale Analysis of Lipid Rafts 
Lipid rafts are thought to serve as platforms for the recruitment and formation of 
signaling complexes upon BCR engagement. One major objective of these studies is to 
determine the components of BCR signalosomes in the context of lipid rafts from highly 
purified T1, T2 and mature B cells.  Due to relatively small numbers of T1 and T2 cells 
that can be purified using FACS, I optimized lipid raft preparation and analysis protocol 
that allowed proteomics and Western blotting analyses. These experiments utilize 2.0 ml 
tubes and centrifugation in a gradient in a Sorvall RP55A rotor. Triton X-100 cell lysates 
from 5x106 purified B cells were passed through an iodixanol block gradient 
(50%/40%/5%)(1). To identify lipid raft fractions, 10% of each 0.2 ml fraction was 
analyzed by Western blot analysis with anti-Lyn antibodies to identify lipid raft fractions. 
The presence of Lyn revealed that the first two fractions were substantially enriched in 
lipid rafts (Fig. 3B). I also investigated whether PLC-γ2 and PKC-βII, which are expected 
to be recruited to lipid rafts upon BCR engagement, can be detected in the raft fractions. 
Indeed, upon stimulation, PLC-γ2 and PKC-βII as well as IgM are recruited to lipid rafts 
(Fig. 3C). Prior to proteomics analysis, I confirmed the presence of lipid raft associated 
proteins. The first two fractions from the iodixanol gradient that were enriched for lipid 
raft associated proteins were precipitated with TCA, fractionated by SDS-PAGE and 
silver stained (Fig. 3D). These results demonstrate my ability to enrich for lipid raft 
associated proteins from as few as 2.5x106 B cells and detect signaling proteins  
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Figure 3. BCR engagement recruits signaling molecules to lipid rafts isolated from 
a small number of primary B cells. (A) Schematic representation of the experimental 
design. Lipid rafts were isolated from 5x106 primary enriched total B cells that were 
stimulated or not with 20 µg/ml of anti-IgM F(ab’)2.  Cells were lysed in a non-ionic 
detergent (Triton X-100) and separated by high-speed centrifugation through an iodixanol 
block gradient to enrich for lipid rafts. Fractions were collected and subjected to SDS-
PAGE analysis. (B) 1/10th of each fraction was separated by SDS-PAGE and analyzed 
by Western blotting. Detection of Lyn shows enrichment of lipid rafts. (C) Representative 
samples of raft and cytosol fractions were immunoblotted with antibodies for indicated 
signaling proteins. (D) Fractions 1 and 2 were pooled and TCA precipitated, denatured in 
SDS-PAGE buffer, subjected to SDS-PAGE and silver stained.   
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recruited to rafts following BCR stimulation. Additionally, these results established the 
feasibility of my microscale lipid raft preparations for further analyses including mass 
spectrometry.  
Proteins Associated with Cellular Organelles Are Not Detected in Lipid Raft 
Preparation 
 
My objective is to identify the T1 and T2 specific BCR signaling proteins recruited 
into lipid rafts. When isolating lipid rafts, one of the concerns that arise is the 
contamination of non-plasma membranes in the fractions. To address this I used a non-
ionic detergent to solubilize the plasma membrane and isolated lipid rafts through 
fractionation by density gradient ultracentrifugation at a microscale. The purity of raft 
preparations was determined by assessing the presence of non-raft proteins of 
lysosomal (LAMP1), Golgi (GM130), ER (GRP78) and mitochondrial (Bcl-2) origin. 
Results in Fig. 4 show that these non-raft proteins are not detected in raft fractions 
isolated from either non-stimulated or BCR stimulated cells by immunoblotting. These 
results demonstrate that my lipid rafts preparations are not contaminated with detectable 
amounts of non-raft proteins and are therefore suitable for mass spectrometric analysis 
of known and novel proteins recruited to lipid rafts in response to BCR engagement. 
 
Recruitment of IgM, Syk, PLC-γ2 and PKC-βII in T1 and T2 B Cell Lipid Rafts 
It has previously been shown that T1 cells are capable of raft independent 
signaling and therefore unable to cap upon BCR crosslinking. Since one of my major 
goals is to identify molecules recruited into lipid rafts upon BCR engagement in each 
particular subset I wanted to address this concept. Therefore I showed through confocal 
microscopy that the BCR colocalizes with GM1 in T1 B cells just as well an in T2 B cells 
(Fig. 5A). To investigate BCR signaling proteins that are known to be recruited into lipid 
rafts in B cells, I probed lipid raft fractions from T1, T2 and mature B cells for the 
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Figure  4. Proteins associated with other cellular organelles are not detected in 
our lipid raft preparations. Lipid rafts were isolated from 5x106 primary enriched B 
cells that were stimulated or not with 20 µg/ml of anti-IgM F(ab’)2. Cells were lysed in a 
non-ionic detergent (Triton X-100) and separated by high-speed centrifugation through 
an iodixanol block gradient to enrich for lipid rafts. Fractions were collected and 
subjected to SDS-PAGE analysis. 1/10th of the raft and non-raft fractions were 
separated by SDS-PAGE and immunoblotted with antibodies to GM130 (Golgi), GRP78 
(ER), LAMP1 (lysosome) and Bcl-2 (mitochondrial) proteins. Fraction 2 was most 
enriched for lipid rafts as determined by immunoblotting for Lyn and Flotillin-2 (data not 
shown). 
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Figure 5. BCR engagement recruits phosphorylated signaling proteins into lipid 
rafts in T1, T2 and mature B cell subsets. (A) GM1 and BCR colocalize in both T1 and 
T2 cells upon anti-IgM stimulation.  T1, and T2 cells were FACS purified as described in 
Fig. 4.  Cells were stimulated with Cy5-labeled anti-IgM F(ab')2 fragment or vehicle 
control as indicated.  Cells were stimulated for 5 min and stained with FITC-labeled 
Cholera toxin to visualize lipid rafts. FITC-labeled anti-HSA or anti-CD40 antibodies were 
used as a negative control for capping (data not shown).  Non-stimulated samples were 
fixed before staining with Cy5-labeled F(ab')2 anti-IgM for 1 h at 4°C, washed twice, and 
stained with FITC-labeled Cholera toxin.  All cells were examined by confocal microscopy 
using argon and helium-neon lasers and visualized at mid-plane at 100 fold 
magnification. (B and C) Purified T1, T2 and mature B cells (4x106) were stimulated for 5 
min with 20 µg/ml of anti-IgM F(ab’)2. Samples were processed as in Fig. 3. (B) 1/10th of 
raft and cytosolic fractions were separated by SDS-PAGE and immunoblotted with 
antibodies for indicated proteins or (C) anti-pY. Presence of Lyn and Flotillin-2 were used 
to identify raft-enriched fractions (data not shown). 
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presence of multiple BCR signaling proteins. Fig. 5B shows that Syk, PLC-γ2 and PKC-
βII are recruited to lipid rafts in T1 as well as T2 and mature B cell subsets. Analysis of 
total protein tyrosine phosphorylated proteins indicates that BCR stimulation leads to 
anincrease in tyrosine phosphorylated proteins in lipid rafts isolated from T2 compared 
to T1 cells (Fig. 5C). These results suggest higher BCR signaling activity in T2 versus T1 
B cells. 
 
Proteomic Analysis of Proteins in Lipid Rafts in T1, T2 and Mature B cells in 
response to BCR Engagement 
 
I employed mass spectrometry to identify previously unrecognized proteins 
specifically in BCR signalosomes that associate with lipid rafts of transitional versus 
mature B cell subsets. This approach allowed the detection of proteins in an unbiased 
method from BCR complexes of T1, T2 and mature B cells, thus independently verifying 
results obtained by Western blot analysis, and allowing the identification of novel 
proteins. To this end I successfully employed mass spectrometry to identify proteins in 
lipid rafts isolated from BCR stimulated T1, T2 and mature B cell subsets (Fig. 6 and 
Table 1). 
 Lipid rafts were prepared from FACS purified T1, T2 and mature B cells (3x106), 
as previously described (2,4) and stimulated with anti-IgM. The enriched fractions for 
lipid rafts in T1 and T2 B cells were concentrated by TCA precipitation and analyzed by 
a state of the art proteomics method termed Direct Analysis of Large Protein Complexes, 
or DALPC (48). The DALPC approach uses multidimensional microcapillary liquid 
chromatography and tandem mass spectrometry to separate and sequence peptide 
mixtures. Denatured and reduced proteins are first trypsin digested to generate a 
mixture of peptides, The mixture is applied to a strong cation exchange chromatography 
column followed by reverse phase column, resulting in a high-resolution two dimensional 
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separation of peptides prior to injection to a tandem mass spectrometer. A software 
algorithm SEQUEST is used to correlate each sequencing spectrum of the fragmented 
peptides with predicted amino acid sequences in translated genomic and protein 
databases (50). This software reassembles the most significantly identified peptides into 
a list of proteins in the original sample (48). The approach allows the unbiased 
identification of proteins at or below the sensitivity of silver stained gels. A large number 
of publications have demonstrated that the approach can identify novel components in 
biological complexes that were missed in earlier studies (48, 52). 
 In order to profile the composition of proteins in lipid rafts a new software 
application to display and compare the profiles of proteins in complex mixtures was 
developed by Dr. Andrew Link. This software is termed BioInformatic Graphical 
Comparative Analysis Tools (BIGCAT) (50). This new software greatly expands the 
options and statistical tools for interpreting, analyzing and comparing the composition of 
proteins in complex mixtures.  Using this proteomic approach, I have obtained data from 
T1, T2 and mature B cell subsets (Fig. 6 and Table 1). Peptide sequences obtained from 
lipid rafts isolated from anti-IgM stimulated T1, T2 and mature B cells identified 195 
distinct proteins in T1, 114 in T2 and 172 proteins in mature B cells. Of these, 91 were 
unique to T1, 38 were unique to T2 and 70 unique to mature B cells (Fig. 6A). Proteins 
known to be associated with other cellular organelles, as well as structural proteins were 
excluded from the analysis. I identified proteins covering several functional classes 
involved in signal transduction, as well as products of genes only reported as ESTs or 
considered as hypothetical proteins.  
 A select set of proteins identified in T1, T2 and mature cells is shown in Table 1. 
Identification of CD45-associated protein (CD45-AP) and two subunits of protein 
phosphatase 2A (PP2A), as well as a novel adaptor protein Src Kinase Associated 
Phosphoprotein (SKAP55) specifically in T1 B cell subsets was particularly intriguing. 
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CD45 is a receptor-like protein tyrosine phosphatase (PTP), which is critical for B cell 
development and selection (Nature, 381:325, 1996). The peptide sequence and MS 
spectrogram that identified this molecule, as well as its domain structure are shown in 
Figure 6B. A recent report indicates that CD45-AP enhances the phosphatase activity of 
CD45 by inhibiting its dimerization during T cell activation (Blood, 103:3440, 2004). 
Consequently, gene deletion of CD45-AP reduces PTP activity of CD45. Recruitment of 
CD45-AP in response to BCR stimulation preferentially in T1 may therefore increase 
PTP activity and dephosphorylate BCR induced tyrosine phosphorylation of BCR 
signaling proteins. This hypothesis is consistent with a reduction in total protein tyrosine 
phosphorylation in T1 B cells (Fig. 5C) 
 PP2A is a serine/threonine phosphatase with multiple functions in cellular growth 
(Blood, 92:539, 1998). It inhibits MAPK and AKT activity and activates pro-apoptotic 
proteins of the Bcl-2 family. Recruitment of PP2A into lipid rafts together with BCR in T1 
cells may contribute to the observed T1 cell death in response to BCR engagement. 
However, I cannot draw any conclusions until these results are verified in multiple 
experiments with non-stimulated and BCR stimulated T1, T2 and mature B cell subsets.  
Proteomic analysis revealed various unidentified proteins covering several 
functional classes involved in signal transduction, such as genes only reported as ESTs 
or by Riken Cell Bank (Japan).  A significant number of these proteins contained 
domains that are known “signatures” of signaling proteins (kinase, SH2, SH3, PH and C1 
domains), fulfilling my criteria for selection for further characterization.   A database 
search of a 26 amino acid peptide sequence obtained from BCR stimulated T1 B cells 
revealed that this peptide sequence was derived from a cDNA clone reported by Riken 
Cell Bank.  The deduced amino acid sequence contained a PH domain and an SH3 
domain.  Further analysis with the deduced amino acid sequence revealed that this 
sequence corresponds to Src Kinase Associated Phosphoprotein (SKAP55). SKAP55 is  
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Figure 6.  MS analysis of lipid rafts isolated from BCR-stimulated T1, T2 and 
mature B cell subsets.  (A) Comparison of proteins identified in T1, T2 and 
mature B cells. Peptides obtained from DALPC that identified (B) CD45-AP, and 
(C) SKAP55. The MS/MS spectrums which significantly correlated with peptides 
to CD45-AP and SKAP55 are shown. 
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B Cell Protein Name Description
T1 PAK2 Activated by CDC42/p21
Tyrosine-protein Kinase CSK Tyrosine phosporylates SRC Kinase
CD45-associated protein Interacts with CD45 and augments PTP activity
Calmodulin Regulates enzymes in a Ca2+ dependent manner
Protein phosphatase 2A, structural A subunit Plays a role en cell survival signaling
Protein phosphatase 2A, regulatory B subunit (PTPA) Plays a role en cell survival signaling
Rho GDP-dissociation inhibitor 2 Regulates GDP/GTP dissociation of GDP from Rho proteins
Rho-related GTP-binding protein RhoC Regulates receptor induced signal transduction
GDP binding protein, bete polypeptide 2-like 1 Receptor, Kinase activity
Proteasome activator complex subunit 2 Required for efficient antigen processing
SKAP55 Adapter protein involved in CD45 T-cell signaling
CDP-diacylglycerol-inositol 3- phosphatidyltransferase Phospholipid biosynthesis
T2 Serine/Threonine kinase 10 Ste20 familiy member, involved in cell adhesion and regulates Plk1
Indian hedgehog Involed in osteogenesis and epithelial cell differentiation
Retinoblastoma binding protein 6 May be involved in growth control and differentiation
Ubiquitin specific proetease 16 ubiquitin-dependent protein catabolism
CD37 Plays a role in T-B cell activation
Glycosyltransferase 28 domain containing 1 Lipid glycosylation, carbohydrate binding
M MAP3K12 binding inhibitory protein 1 Inhibits MAP3K12 activity to induce activation of JNK/SAPK pathway
Cdc42 homolog Small GTPase, signal transduction
Transforming protein RhoA Regulates receptor induced signal transduction
Proteasome subunit alpha type 1 Protein Degradation
Ubiquitin-activating enzyme E1 X Activates ubiquitin
Protein tyrosine phosphatase S Possibly a cell adhesion molecule.
Inositol 1 (or 4) monophosphatase Phosphatidylinositide metabolism
Lymphocyte specific protein 1 Thought to be involved in signal tranduction by calcium binding
Table 1. Select examples of the proteins identified by DALPC in lipid rafts isolated from 
anti-IgM stimulated T1, T2 and mature (M) B cells 
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a 55 kD protein, which is comprised of a unique N-terminal region, a PH domain, 
followed by three tyrosine residues and a SH3 domain (Fig. 6C).   Studies in human T 
cell lines have shown that SKAP55 binds to the catalytically active site of CD45. 
SKAP55 a substrate of CD45 (67, 73) also binds to Src family kinases  (SFKs) 
via their SH2 domains.  Prior studies have also shown that, in T cells, the SH3 domain of 
SKAP55 binds to the central proline rich region of other adapters SLAP-130 and ADAP, 
thereby connecting SKAP55 to signaling pathways that control cell adhesion and 
migration (61).  However, SKAP55 function in B cells remains entirely unknown. 
 
CD45-AP Deletion enhances BCR induced Tyrosine Phosphorylation and Affects 
B Cell Developmental Progression 
 
Through proteomics and mass spectrometry, I identified CD45-AP in lipid rafts isolated 
from T1 cells. CD45-AP is an adaptor molecule that binds to CD45 and enhances its 
phosphotase activity by inhibiting the dimerization of CD45 on the cell membrane. 
Previous studies on CD45-AP deficient (CD45-AP-/-) mice showed that these mice had a 
similar phenotype but significantly weaker, to CD45 knockout mice in regards to T cell 
activation. These studies showed that CD45-AP-/- had no apparent effect in B cell 
development. I wanted to examine whether CD45-AP had an effect on B cell signaling 
and further characterize its effect on B cell development. Lipid rafts were isolated from 
wt and CD45-AP-/- cells as described in materials and methods. Cells were left 
unstimulated or stimulated with 20 µg/ml of anti-IgM. Fractions were collected, run on 
SDS-PAGE and probed with 4G10 (anti-phosphotyrosine). What I observed was that 
CD45-AP-/- cells had more detectable tyrosine phosphorylation in lipid rafts as compared 
to wt cells (Fig. 7). Surprisingly, wt type cells had more tyrosine phosphorylation in the 
cytoplasmic fractions than the cytoplasmic fractions of the CD45-AP-/- cells (Fig. 7). This  
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Figure 7. CD45-AP deficiency affects tyrosine phosphorylation in lipid rafts 
after BCR engagement. Lipid rafts were isolated from 5x106 primary enriched B 
cells from wt or CD45-AP-/- mice. Cells were stimulated or not with 20 µg/ml of anti-
IgM F(ab’)2. Cells were lysed in a non-ionic detergent (Triton X-100) and separated 
by high-speed centrifugation through an iodixanol block gradient to enrich for lipid 
rafts. Fractions were collected and subjected to SDS-PAGE analysis. 1/10th of the 
raft and non-raft fractions were separated by SDS-PAGE and immunoblotted with 
4G10 (anti-tyrosine phosphorylation). 
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suggests a possible role for CD45-AP would be to regulate the threshold of CD45 
signaling required for B cell activation.  
 The observed effect of loss of CD45-AP on BCR induced tyrosine 
phosphorylation led me to investigate if CD45-AP absence affected B cell development. 
Previous studies did not detect any apparent phenotypic alterations in B cell 
development in CD45-AP-/- mice (68, 70). To determine if B cell development is affected, 
wt and CD45-AP-/- cells from two different ages were stained with antibodies to identify 
populations as previously described. Upon examination of the data, I observed that at 4 
weeks, CD45-AP-/- mice had a higher percentage of immature cells as compared to wt 
mice (Fig. 8). At 16 weeks CD45-AP-/- had a lower percentage of immature B cells when 
compared to wt cells (Fig. 8). This data suggest that loss, CD45-AP may accelerate B 
cell development, which is only apparent with ageing. Consistent with my hypothesis, I 
found that at 16 weeks there was an increase in the percentage of marginal zone B cells 
(16%) when compared to wt cells (4%). These data demonstrate that CD45-AP 
deficiency does affect B cell development in a stage specific manner with age. 
  
Differential Expression of SKAP55 in T1 versus T2 B cell subsets 
My mass spectrometry results that SKAP55 is found in lipid rafts of BCR 
stimulated T1 cells prompted me to investigate the expression of this protein within the 
two transitional B cell subsets.  RT-PCR was performed with primers flanking exon 2 and 
5 on the RNA isolated from FACS purified T1 and T2 cells as described (Fig. 2) and from 
murine thymocytes.  As expected, T cells express SKAP55 mRNA (Fig. 9A).  SKAP55 
mRNA expression was also clearly detected in T1 cells (Fig. 9A).  In contrast, PCR 
amplicon was barely detectable in T2 cells (Fig. 9A).   Consistent with mRNA expression 
profile, SKAP55 protein was also detected in T1 cells (Fig. 9B). This protein was 
detected in total purified B cells at significantly reduced levels probably due to a small T1  
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Figure 8. Age-dependent accumulation of transitional Vs. MZ B cells in 
CD45-AP-/- Mice. Freshly isolated wt (1x106) and CD45-AP-/- splenocytes were 
labeled with the indicated B cell phenotypic markers, and analyzed by FCM. (A) 
CD19+ B cells. Transitional and mature B cell subsets are plotted based on AA4.1 
expression. (B) CD19+ B cells. Mature (FoB) and marginal zone (MZ) B cell 
subsets are plotted based on CD23 and CD21 expression. 
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Figure 9. SKAP55 is specifically expressed in T1 cells.  (A) SKAP55 mRNA is 
selectively expressed in T1 but not T2 B cells. Total RNA (100 ng) purified from 
FACS-sorted T1 and T2 B cells as well as primary T cells (positive control) was 
subjected to semiquantitative RT-PCR for SKAP55 transcript. The amplified 
products were analyzed by TBE-polyacrylamide gel followed by ethidium bromide 
stain. GAPDH was used as a housekeeping gene.  (B) SKAP55 protein is 
detected exclusively in T1 cells. Total cell lysates from 1.5x106 primary enriched 
total B cells; T cells and FACS-sorted T1 B cells were run on SDS-PAGE and 
immunoblotted with anti-SKAP55.  p38 was used as a positive control for protein 
loading. 
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cell contribution.  These results confirm that SKAP55 is expressed preferentially in the 
T1 cell subset within the B cell compartment.  SKAP55 is known to be expressed in T 
cells, where it serves as an adapter protein that couples Fyn and other Src kinases to 
the PTPase of CD45 (73).  The expression of SKAP55 preferentially in T1 cells and its 
known function in T cells clearly warrant investigation of its interactions with Src family 
kinases in T1 cells, in particular Lyn, and determination of its function in T1 cell selection 
and maturation process. Together, these results verify the reliability of the proteomic 
approach to identify molecules involved in stage-specific BCR signaling events. 
 
Recruitment of PP2A Subunits to Lipid Rafts in Total B Cells 
Protein phosphotase 2A (PP2A) is a multimeric protein that has been described 
in multiple signaling pathways involved in cell growth, differentiation and apoptosis 
among others. Two subunits of PP2A were identified by proteomic analysis in rafts 
isolated from highly purified T1 B cells (Table 1). To investigate the role that PP2A plays 
in BCR signaling I verified the recruitment of PP2A subunits to lipid rafts isolated from 
total B cells. I probed lipid raft fractions from total B cells for the catalytic subunit of 
PP2A (PP2A/c) and for one of the regulatory subunits (PTPA/PR53) that was identified 
by proteomic analysis. Fig. 10A shows that PP2A/c and PTPA/PR53 are recruited to lipid 
rafts upon BCR crosslinking in total B cells. PKC-βII was used as a control to 
demonstrate recruitment into lipid rafts. Prior studies suggest that PP2A plays a role in 
NF-κB signaling. In collaboration with Dr. Brian Wadzinski investigated the role of PP2A 
in NF-κB activation (65). Previous studies suggest a possible interaction between PP2A 
and the IKK complex. To validate, I performed coimmunoprecipitations to determine if 
PP2A interacts with the IKK complex. As shown in Fig. 10B, PP2A or IKKγ 
coimmunoprecipitate with both IKKα and PP2A. Since IKKγ was used for the  
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Figure 10. BCR engagement recruits PP2A/c into lipid rafts and PP2A Co-
immunoprecipatates of IKK subunits in total B cells. Enriched B cells (4x106) 
were stimulated for 5 min with 20 µg/ml of anti-IgM F(ab’)2. Samples were processed 
as in Fig. 3. (A) 1/10th of raft and cytosolic fractions were separated by SDS-PAGE 
and immunoblotted with antibodies for the indicated proteins. Presence of Lyn and 
Flotillin-2 were used to identify raft enriched fractions (data not shown). (B) Cell 
extracts from purified primary B lymphocytes were incubated with the PP2Ac 
monoclonal antibody (Transduction Lab) and protein G-Sepharose or the IKKγ 
polyclonal (FL-419) antibody and protein A-Sepharose and the corresponding IgG 
controls. The resulting immune complexes were washed, eluted with SDS sample 
buffer and subjected to SDS-PAGE and probed with antibodies against IKKα and 
PP2Ac. 
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immunoprecipitation, this suggests that PP2A is associated with the classical NF-κB 
pathway which is the pathway targeted by BCR engagement. While a function for 
PP2A/NF-κB pathway in T1 B cells remains to be determined, these results verify the 
reliability of the proteomic approach to identify molecules involved in stage-specific BCR 
signaling events. 
 
Discussion 
   Splenic B cells can be divided into at least three developmental subpopulations, 
Transitional type 1 (T1), Transitional type 2 (T2) B cells and mature B cells. Previous 
studies have revealed that T1 and T2 B B cell subpopulations display distinct responses 
to similar stimuli.  For example, in response to IgM crosslinking, T1 B cells die whereas 
T2 B cells proliferate and differentiate into a mature B cell phenotype.  My hypothesis 
was that the composition of the BCR signalosome is altered in T1 to T2 B cell transition. 
To test this hypothesis I determined the effects of the BCR stimulation on the 
translocation of signaling proteins into lipid rafts (Figs. 3C and 5B). My results showed 
that T1, T2 and mature B cells were capable of recruiting known BCR associated 
molecules such as IgM, Syk, PLC-γ2 and PKC-βII (Fig. 5B). The ability of all subsets 
being able to recruit these molecules leads me to examine whether activation of these 
molecules was occurring to the same extent.  When I inspected the levels of tyrosine 
phosphorylation in lipid rafts isolated from stimulated T1, T2 and mature B cells, I found 
that T1 cells had less detectable tyrosine phosphorylation when compared to T2 cells. 
These data suggest that even though all these B cell subsets recruit known major 
molecules involved in BCR signaling to lipid rafts, they are being differentially regulated, 
possibly within the lipid rafts.  
This outcome could be due to the recruitment of unsuspected and/or unknown 
molecules. Therefore, I employed a novel mass spectrometric approach known as Direct 
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Analysis of Large Protein Complexes (DALPC), to characterize and identify known and 
novel proteins specifically in BCR signalosomes that associate with lipid rafts of T1, T2 
and mature B cell subsets. A number of known proteins as well as novel proteins were 
identified (Fig. 6 and Table 1). An abundance of proteins that are involved in 
phosphotase activities were selectively identified in T1 B cells (Table 1). The 
serine/threonine phosphatase PP2A, CD45 associated protein (CD45-AP) and a never 
before identified protein in B cells, SKAP55. These were of particular interest, due to our 
previous results showing decreased tyrosine phosphorylation in lipid rafts isolated from 
T1 B cells (Fig. 5C) and also the differential activation of AKT and MAPK between T1 
and T2 B cells (2).  
PP2A accounts for a majority of the serine–threonine phosphatase activity in 
cells and has been implicated in the regulation of many signaling pathways and 
phenotypes. Typically, the PP2A heterodimer complex is comprised of a scaffolding A 
subunit with an apparent molecular-mass of 65 kDa and the 36 kDa catalytic subunit 
(PP2Ac). This A/C subunit heterodimer interacts with a regulatory B subunit yielding the 
PP2A holoenzyme. My studies show that PP2A is recruited to lipid rafts upon BCR 
engagement in total B cells (Fig. 10A). Prior studies have shown that PP2A can also 
interact with IKKs, dephosphorylates specific residues and possibly have a positive 
regulatory role NF-κB activation. My data shows that PP2A does interact with the IKK 
complex as it co-immunoprecipates with IKKγ (Fig. 10B). These studies were recently 
published in collaboration with Dr. Brian Wadzinski (65). 
CD45 is one of the main regulators of lymphocyte signaling. It is known that upon 
BCR stimulation CD45 dephosphorylates tyrosine residues on Src kinases, leading to 
their activation. These Src kinases then initiate the downstream signaling cascades 
induced by BCR crosslinking. CD45-AP has been shown to augment the tyrosine 
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phosphotase activity of CD45 by preventing CD45 dimerization. Previous studies have 
shown that CD45-AP deficient mice, phenotypically resemble CD45 knockout mice, but 
to a less severe extent. In addition, I observed that upon BCR crosslinking CD45-AP-/-  B 
cells show more detectable tyrosine phosphorylation of proteins in lipid rafts to wt cells 
(Fig. 7). Also, even though there was more tyrosine-phosphorylation in lipid rafts from 
CD45-AP-/- cells, wt cells have increased tyrosine phosphorylation in the cytoplasmic 
fractions (Fig. 7). This increased phosphorylation in rafts from the CD45-AP-/- could be 
that in the absence of CD45-AP the initial membrane proximal events (activation of Src 
kinases) is unaffected, but the downregulatory (downregulation of BCR signaling) role of 
CD45 affected. This would lead to an accumulation of phosphorylated proteins in lipid 
rafts (Fig. 7). Another possibility is that CD45-AP is required for the activation of specific 
membrane proximal signaling events while dispensable for others. If so, then upon BCR 
crosslinking, CD45 is able to activate certain signaling molecules, thereby allowing the 
activation of downstream signaling pathways independent of CD45-AP. In this case, a 
possible role for CD45-AP would be to regulate the threshold of CD45 signaling required 
for B cell activation. A recent report suggested that BCR signaling threshold determines 
B cell fate into FoB (mature B cells) or MZ (marginal zone) B cells. If the absence of 
CD45 does influence BCR signaling threshold, that would explain the accumulation of 
MZ B cells with age in CD45-AP-/- (Fig. 8). 
Adapter proteins primarily mediate protein-protein interactions and control proper 
targeting of signaling molecules to downstream effectors by facilitating the formation of 
specific protein complexes.  Proteomic analysis identified a novel adaptor protein, 
specifically in T1 and not in T2 or mature B cells. This protein was identified as SKAP55. 
Conventional methods confirmed its presence and specificity to T1 cells by RT-PCR and 
by immunoloblotting (Fig. 9). However, these results do not reveal whether SKAP55 is 
constitutively associated with rafts or is recruited there in response to BCR engagement. 
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SKAP55 is a 55 kD (359 amino acid) protein, which is comprised of a unique N-terminal 
region, a PH domain, followed by three tyrosine residues and a SH3 domain (Fig. 6). 
Studies in human T cell lines have shown that SKAP55 binds to the catalytically active 
site of CD45.  SKAP55 a substrate of CD45 (73) also binds to Src family kinases  (SFKs) 
via their SH2 domains including Lyn. Prior studies have also shown that, in T cells, the 
SH3 domain of SKAP55 binds to the central proline rich region of other adapters SLAP-
130 and ADAP, thereby connecting SKAP55 to signaling pathways that control cell 
adhesion and migration (61).  However, SKAP55 function in B cells remains entirely 
unknown. 
I hypothesize that SKAP55 contributes to BCR signaling in T1 cells and promotes 
survival and selection, and that it facilitates migration during T1 cell maturation.  This 
hypothesis predicts that SKAP55 enhances Lyn activation by coupling it to CD45 protein 
tyrosine phosphotase (PTP) activity, by means of dephosphorylating a regulatory 
tyrosine residue(s). This increase in Lyn activity, leads to the enhanced activation and 
association with other regulatory molecules, such as CD22 and SHP-1, thus down 
regulating BCR signaling in T1 B cells (Fig. 11). The absence of SKAP55 in T2 cells 
eliminates this enhanced association of CD45 and Lyn, allowing typical activation and 
signal transduction to occur upon BCR engagement.  
Also SKAP55 may play a role in T1 development is through its interaction with 
ADAP and SLAP-130 to induce cytoskeletal reorganization and migration.  Migration of 
T1 cells into B cell follicles coincides with their transition into T2 cells. The mechanisms 
that control T1 cell adhesion and migration are unclear.  A recent report demonstrated 
that SKAP55 could increase T cell-APC conjugation, adhesion to fibronectin and 
intercellular adhesion molecule-1 (ICAM-1), and enhances integrin- adhesion, raising the 
tantalizing possibility that SKAP55 may facilitate T1 migration into B cell follicles.                             
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Taken together, these results are consistent with my hypothesis that distinct 
signaling pathways are activated in a stage specific manner and that this is responsible 
for the disparate biological outcomes seen upon BCR crosslinking.  
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Lyn
Figure 11. A Model for SKAP55 Regulation of BCR Signaling. 
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CHAPTER III 
 
EXPRESSION PROFILING OF GENES EXPRESSED IN T1, T2 AND MATURE B 
CELL SUBSETS BY MICROARRAY ANALYSIS 
 
Abstract 
The immature splenic B cell subsets termed Transitional Type 1 (T1) and 
Transitional Type 2 (T2) respond differentially to B cell antigen receptor (BCR) 
crosslinking; T1 cells die whereas T2 cells proliferate and differentiate into a mature B 
cell phenotype.  To determine whether genetic reprogramming underlie T1 and T2 B cell 
maturation I employed cDNA microarray to profile gene expression. The observed main 
difference between T1 and T2 B cells is differential sensitivity to cell death, therefore I 
investigated if this was due to changes in the balance of pro- and anti-apoptotic genes 
as well as the NF-κB family of transcription factors which are known to regulate many of 
these survival genes. Expression of pro-apoptotic genes did not show any significant 
difference among T1, T2 and mature B cells, but T1 cells showed lower expression of 
two anti-apoptotic genes, A1 and Bcl-2 both of which are under NF-κB control. These 
results suggest that reduced survival of T1 cells may be due to lower expression of NF-
kB dependent anti-apoptotic genes. Consistent with this I found that T1 B cells had lower 
levels of NF-κB1 and NF-κB2 than T2 and mature B cells. Together, these results 
suggest that gene expression profiling is a feasible approach to help define the unique 
characteristics of the transitional B cell subsets that may underlie their differentiation. 
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Introduction 
Immature B cells progress through at least two transitional stages (T1 and T2) 
within the spleen before developing into a mature B cell phenotype. Our lab has shown 
that purified T1 cells undergo apoptosis in response to IgM cross-linking, whereas T2 
cells survive, proliferate and display a mature B cell phenotype. Currently available data 
suggest that multiple BCR signal transducers are preferentially activated in T2 relative to 
T1 B cells. A crucial step during the differentiation of many cell types is genetic 
reprogramming (51-53). In turn, de novo synthesis of new gene products regulates 
specific molecular processes including changes in the hardwiring of cells as they 
differentiate. Thus, the genetic architecture of each differentiating B cell population is 
likely to contribute to the specific biochemical code at each developmental stage and 
may control distinct cellular responses. An alternative hypothesis to the differences in 
the recruitment of distinct proteins in T1 versus T2 BCR signalosomes would be that the 
distinct biological outcomes in T1 versus T2 cells arise from differences in the gene 
expression profile of BCR signaling proteins that accompany T1 to T2 development. To 
gain insights into the genetic reprogramming that accompanies the differentiation of T1 
and T2 B cells, I determined gene expression profiles in each B cell subset by cDNA 
microarray analysis. 
A DNA microarray is typically used to detect gene expression in RNA samples. 
Total RNA is extracted from the sample tissue. RNA is prepared from the desired tissue 
and primed with anchored oligo-dT, reverse transcribed, and labeled with a fluorescent 
molecule. This labeled target is then allowed to bind to its complement on the microarray, 
and the amount of bound probe is detected by the fluorescence intensity. If the probe 
has been properly designed and the hybridization is stringent enough, the probe will bind 
only to the specific message, and the relative fluorescence of the probe can be used to 
infer the level of gene expression. Therefore, I have used microarray to determine if 
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stage specific biological outcomes in B cell subsets are controlled by transcriptional 
regulation of genes that regulate BCR signaling and cell survival during B cell 
development. 
 
 
Materials and Methods 
 
Cells and Isolation of Pure T1, T2 and Mature B cells 
Refer to Materials and Methods section in chapter 2. 
 
Affymetrix Microarray Analysis 
Approximately 1.5-5x106 T1, T2 and mature B cells were isolated on a 
FACStarTM fluorescent cell sorter as mentioned previously. Total RNA was extracted 
from these samples utilizing the QIAGEN RNA mini prep. The samples were quantified 
in 10mM Tris on the Nanodrop ND-1000 Spectrophotometer by the Vanderbilt 
Microarray Shared Resource center (VMSR). In addition to concentration, this 
instrument reports the 260/280 absorption ratios, which can be an important indicator of 
hidden contaminants. The samples were then analyzed on an Agilent 2100 Bioanalyzer. 
The electropherogram it produces makes it easy to spot certain contaminants or 
degradation, and to calculate the 28s:18s ratio. All samples were hybridized to 
Affymetrix Mouse 2.0 arrays. This array provides coverage of the transcribed mouse 
genome on a single array, including 39,000 transcripts, representing, 34,000 well 
characterized mouse genes. 
 
PIQORTM Microarray Analysis 
1.5x106 T1, T2 and mature B cells were isolated on a FACStarTM fluorescent cell 
sorter as mentioned previously. The cells were then frozen in liquid nitrogen and 
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prepared for shipment to Miltenyi Biotec laboratories. RNA was prepared using the M&N 
RNA II Kit. The samples were then analyzed on an Agilent 2100 Bioanalyzer system. 
There was not enough material available for T7 based linear amplification, therefore 
SuperAmplification was performed according to Miltenyi’s undisclosed protocol.  The 
samples were quantified on the Nanodrop ND-1000 Spectrophotometer. Probe labeling 
was performed according to Miltenyi Biotec’s undisclosed protocol. 250 ng each of Cy3 
or Cy5 fluorescently labeled probes were subsequently hybridized on PIQORTM 
Immunology Mouse Microarrays and subjected to overnight hybridization using a 
hybridization station. Cy5 (red) was used to probe the experimental samples and Cy3 
(green) the control samples. Two hybridizations were performed, one comparing T1 
(experimental) vs. T2 (control) and the other mature (experimental) vs. T2 (control).  
 
 
Results 
 
Gene Expression Profiles of Stimulated T1, T2 and Mature B Cell Subsets by 
Affymetrix 
 
Others and I have shown that T1 and T2 B cells respond differently to BCR 
stimulation. The major observable difference is cell death, T1 cells die where as T2 
proliferate and resemble a mature B cell phenotype. To determine if these disparate 
responses are due to changes in the BCR signaling proteins and balance of pro- and 
anti-apoptotic genes, I performed a whole genome microarray analysis. RNA was 
isolated from T1, T2 and mature B cells that were either left unstimulated or stimulated 
with 20 µg/ml of anti-IgM for 1 hour. Additional samples of only T2 and mature B cells 
were also stimulated for 18 hours. All the samples were hybridized to Affymetrix Mouse 
2.0 arrays. The data analysis is focused on comparisons where all three subsets are 
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included, with a particular focus on BCR signaling related genes and both anti- and pro-
apoptotic genes. 
 Known BCR signaling molecules where analyzed (Syk, BTK, PLC-γ2, etc.) but 
showed no difference between T1, T2 and mature B cells (data not shown). Table 2 
shows the anti- and pro-apoptotic genes that were at least 2 fold different among the B 
cell populations when compared to each other. The highlighted genes represent anti-
apoptotic genes. In non-stimulated samples, T1 cells had lower levels of anti-apoptotic 
genes when compared to either T2 or mature B cells. Of particular interest were A1 and 
Bcl-2, which are anti-apoptotic genes known to play an important in role B cell survival. 
These genes were consistently lower in T1 compared to T2 and mature B cells, both in 
non-stimulated samples and after 1 hour stimulations. Additionally I found that T1 B cells 
did not show an increase in the amount of pro-apoptotic genes when compared to T2 
and mature B cells.  
I also compared survival genes that were either upregulated or downregulated 2 
fold within each particular subset, to determine the ability of each subset to regulate 
these genes, comparing non-stimulated and 1 hour stimulations. Table 3 represents the 
genes that were identified in this analysis. I observed that all three B cell subsets were 
cable of upregulating and down regulating both anti- and pro-apoptotic genes to the 
same degree. Taken together the information from this analysis with one where each 
subset was compared to another, these suggest that the main difference in T1 B cell 
may be lower expression of the anti-apoptotic genes. 
  
NF-κB Related Gene Expression Profiles of Stimulated T1, T2 and Mature B Cells 
by Affymetrix 
 
It is known that expression of survival genes is targeted by BCR engagement. 
Because survival genes are targeted by NF-κB upon BCR engagement, therefore I  
 40 
 Table 2. Survival genes differentially expressed among non-stimulated and stimulated T1, T2 and mature B cells by Affymetrix 
Time Name Fold Accesion
T1 fold relative to T2 0h Pim1 5.28 AI323550 
T2 fold relative to T1 0h A1 6.5 L16462.1 
Bcl-2 55.72 BM119782 
Bcl-2 2.14 BI664467 
Bim 8 BE686465 
T1 fold relative to M 0h Nip2 388.02 AK017785.1 
PUMA 42.22 NM_008611.1  
M fold relative to T1 0h A1 5.28 L16462.1 
c-IAP
Bcl-2
Bcl-2
Bcl-2
Bcl-2
Birc2
Bid 
Nip3L
Nip3L
Nip2
Bnip1
Bim
T1 fold relative to T2 1h c-IAP
PUMA
T2 fold relative to T1 1h A1a
A1c
Pim
T1 fold relative to M 1h c-IA
PUMA
M fold relative to T1 1h Bcl-2
A1a
T2 fold relative to M 0h Diva
Nip2
M fold relative to T2 0h Bcl-2
Bcl-2
c-IAP
c-IAP
Bax
Bid
Nip1
M fold relative to T2 1h A1a
The highlighted areas represent Anti-apopt
 
Genes indicated by asterisks (*) are genes 
minimum used to determine reliability. Thes
additional methods. 
 *
16 NM_134141.1 
90.51 BM119782 
5.28 AI505544 
4.92 BB030997
2.46 BI664467 
2.83 NM_007465.1
2.83 BC002031.1 
2.14 AK004667.1 
2 AK018668.1
2.83 NM_016787.1  
4.59 BG073508 
7.46 BE686465 
5 2.83 BC004702.1 
34.3 NM_008611.1 
3.48 AI326167 
27.86 NM_007535.1 
2 AV309401 
4.59 BC004702.1
3.48 NM_008611.1  5
** 
3
P*
*1*2 BI664467 
6.5 AI326167 
25.99 NM_013479.1 
6.06 AK014659.1 
2.14 AI505544 
3.73 BB030997
1 2.14 NM_134141.1 
1 3.48 NM_134141.1 
2.46 BC018228.1 
2.64 BC002031.1 
2.83 BG073508 
2 AI326167 
otic genes.
whos signal intensity were below the 
e genes have to be confirmerd through 
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Time Name Fold Accesion
T1 Fold Increase 1h A1 5.66 L16462.1
Mcl1 2 BC003839.1
BimL 19.7 AF032460.1 
Bcl-2 29.86 BM119782
c-IAP
 
24.25 NM_134141.1
c-IAP2 2.3 NM_007465.1
c-IAP5 2 BC004702.1
Bim 27.86 BE686465 
Bim 5.66 BM120925 
Bim 4 BB667581
Bim 3.48 BB667581 
Bim 6.06 AW411692
Nip1 2.3 BG073508
T1 Fold Decrease 1h Nip2 181.02 AK017785.1
PUM 5.28 NM_008611.1 
Bcl2-l14 9.85 BC025541.1
T2 Fold Increase 1h A1a 4.29 AI326167  
c-IAP1 2.46 NM_134141.1 
c-IAP1 4 NM_134141.1 
Bax 2.46 BC018228.1
BimL 24.25 AF032460.1  
Bim 3.25 BE686465 
Bim 6.5 BM120925 
Bim 2.3 BB667581 
Bim 5.28 BB667581 
Bim 3.25 AW411692 
Bcl2-l13 2.64 BC027307.1 
T2 Fold Decrease 1h Mcl1 2 AV318494 
Bcl-2 3.25 BC027249.1
Bcl-w 3.25 BE991142
Nip2 4 AK014659.1 
Bcl2- 2 6.96 BB227384 
M Fold Increase 1h A1a 7.46 AI326167  
Bcl-x 2 BM228788 
Bcl-x or 2.46 U10100.1 
BimL 6.96 AF032460.1 
Bim 3.03 BE686465 
Bim 8 BM120925 
Bim 3.25 BB667581 
Bim 5.66 BB667581 
Bim 11.31 AW411692
M Fold Decrease 1h Bcl-2 3.48 BC027249.1 
Bcl-2 3.73 AI505544
Bcl-2 5.66 BB030997 
Nip2 2 AV144704
Bad 2.14 NM_007522.1  
Bid 2 BC002031.1 
Nip2 2.3 AK014659.1 
The highlighted areas represent Anti-apoptotic genes.
1
A
 
 l1
 sh t 
 *
*
*
*
**
*
**
*
**
Table 3. Survival genes differentially expressed within non-stimulated 
and stimulated T1, T2 and mature B cells by Affymetrix 
Genes indicated by asterisks (*) are genes whos signal intensity were below the 
minimum used to determine reliability. These genes have to be confirmerd through 
additional methods. 
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determined whether these transcription factors and their upstream regulators were 
expressed differentially among the B cell populations.   
T1 and T2 B cells had similar levels of most the inhibitors of κB (IκBs) and 
Inhibitors of κB kinases (IKKs) in both stimulated and non-stimulated samples (Table 4). 
The most important difference was that non-stimulated T1 cells had lower levels of NF-
kB1 (p105/p50) and NF-kB2 (p100/p52) when compared to both T2 and mature B cells. 
Interestingly I found that most of these genes were consistently higher in non-stimulated 
mature B cells, when compared to both T1 and T2 cells. However, these differences 
were not observed after BCR stimulation. This suggest that both T1 and T2 B cells are 
capable of upregulating these genes at similar levels as mature B cells, or that after 
stimulation, mature cells, downregulate these genes to the same level as T1 and T2 B 
cells. In either case, it appears BCR stimulation similarly regulates components of NF-κB 
signaling both in T1 and T2 B cells as well as in mature B cells. A higher level of NF-κB 
subunits in the mature B cells suggests increasing dependence of B cells on NF-κB with 
maturation. 
 
Gene Expression Profile Analysis of Freshly Isolated T1, T2 and Mature B cells 
PIQOR 
 
One question that is frequently asked is if the response of purified cells after 
culture is representative of the in vivo response, especially in the context of development. 
To address this question I preformed microarray analysis of freshly isolated B cell 
subsets. T1, T2 and mature B cells were purified as shown in figure 2. This B cell 
purification scheme excludes a T2 B cell population which is thought to serve as 
precursors for MZ B cells. The cells were submitted to Miltenyi Biotec laboratories to 
perform focused gene expression analysis with PIQORTM Microarrays. These 
microarrays are designed to cover genes in select groups including, signaling and cell  
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Table 4. NF-κB and related gene expression in non-
stimulated and stimulated T1, T2 and mature B cells by 
Affymetrix. 
Fold Gene
Higher in T1 non Vs T2 non
3.03 IkBα
Higher in T2 non Vs T1 non
2.64 NF-κB1 (p105) 
Higher in M non Vs T1 non
2.83 NF-κB2 (p100)
2.46 IκBζ (zeta)
2 IκBα
3.73 IκBβ
2.14 IκBε
2 IκBε
4 NF-κB1 (p105) 
2 IKKβ
2.3 IKKγ
Higher in M 1h Vs T1 1h
2.3 IKKε
Higher in M non Vs T2 non
4.92 NF-κB2 (p100)
2 IkBζ (zeta)
2.14 IκBα
6.96 IκBβ
2.14 IκBε
2.14 IκBε
12.13 IKKβ
2.3 IKKβ
Higher in M 1h Vs T2 1h
2.64 IKKε
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death among others. The Immunology microarray includes 1,076 key genes for immune 
response, cell death, extracellular matrix, and signal transduction helping to understand 
the network and the underlying gene regulation of signaling pathways. Two 
hybridizations were performed, one comparing T1 (experimental) vs. T2 (control) and the 
other mature (experimental) vs. T2 (control). A focus of these studies was to investigate 
differences among genes that encode proteins involved in the regulation of BCR 
signaling. Additionally, since the major difference among T1, T2 and mature B cells is 
survival, I also analyzed the expression of anti- and pro- apoptotic genes and 
components of the NF-κB signaling pathways. 
Consistent with the data obtained with Affymetrix, analysis of these data 
demonstrated that there is no significant difference in the expression levels of BCR 
associated signaling molecules in resting T1, T2 and mature B cells (data not shown). 
However examination of the anti-apoptotic genes revealed that Bcl-2 and A1 transcripts 
were expressed approximately 2 fold less in T1 compared to T2 B cells (Table. 5, 
highlighted)(These data are consistent with the results obtained from the Affymetrix 
microarray, Table. 2). These genes were not differentially expressed in T2 and mature B 
cells when compared. T1 B cells also express 2 fold lower levels of Bcl-2 and A1 when 
compared to mature B cells. Surprisingly another anti-apoptotic gene, Pim-1 was 
expressed 2 fold higher in T1 cells when compared to T2 and mature B cells Table. 5). 
There are no detectable differences in the expression of pro-apoptotic genes within 
these subsets. These data are also consistent with the results obtained from the 
Affymetrix array. Prior knockout studies have shown that loss of Bcl-2 deficiency results 
in an age-dependent decline of B lymphocytes. Whether modest lower levels of A1 and 
Bcl-2 in T1 relative to T2 cells have a developmental stage specific biological 
significance remains to be elucidated.  
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Table 5. List of genes differentially expresses in freshly isolated T1 
and T2 B cells from the PIQOR microarrays. 
Gene Fold Accesion
IL18 2.25 P70380
IFN-GAMMA 3.27 P01580
CL-2 2.04 P10417
TNFRSF11A (RANK) (RECEPTOR ACTIVATOR OF NF-KB) 2.44 Q8VCT7
LT-ALPHA (TNF-BETA) 1.92 P09225
1 (BFL-1) 2.17 Q07440A
CD87 2.38 P35456
THY1 (CD90) 5.56 P01831
CD96 2.32 Q99M67
CD21 1.74 P19070
KI67 (MKI67) 2 Q61769
KIAA0042: (KIAA0042 OR KIF14) KINESIN-LIKE PROTEIN KIF14. 2.44 O35064
BMP-8 (OP 2). 2.38 P34821
CYR61 (IGFBP10 OR GIG1 OR CCN1) 2.04 P18406
TGF-BETA 3 2.27 P17125
GREM2 2.32 O88273
DOC2 BETA. 2.7 Q6NXK3
APXL 2.7 Q8CDZ0
MPP2 (MAGUK P55 SUBFAMILY MEMBER 2) 3.03 Q9WV34
FAK1: (FAK1 OR FAK OR PTK2) 2.7 P34152 
CCR8: (CCR8 OR CMKBR8 OR CKRL1 OR TER1) 2.22 P56484
STMN1 (STMN1 OR LAP18 OR OP18) 2.63 P54227
COL9A2 (ALPHA-2 IX COLLAGEN) 2.5 Q07643
LAMB1 (LAMININ B1 CHAIN) 2.13 P02469
FIP (FOS-INTERACTING PROTEIN) 2.22 Q64705
SMALL INDUCIBLE CYTOKINE A17 2.78 Q9WUZ6
CXCL13 (BLC OR BCA1) 2.32 O55038
CD118 (IFN-ALPHA-REC) 2.38 P33896
GRL (GRL OR NR3C1) 2.04 P06537
TRAF1 2.22 P39428
SMAD5 2.78 P97454
FLAP: (ALOX5AP) 5.32 P30355
IM1 2.13 P06803PBMGST1 (MGST OR GST12) 1.9 Q91VS7
AOC3 (VAP1) 2.22 O70423
DR6 (TNFRSF21) 2.27 Q91XH9
FCP1 (CTDP1) 1.92 Q7TSG2 
HHEX (PRHX OR PRH OR HEX) 2.02 P43120
LGALS3 (LECTIN L-29) 2.75 P16110
RGS2 (G0/G1 SWITCH REGULATORY PROTEIN 8). 1.73 O08849 
CD44 2.56 Q05732 
TGFBI (BIGH3) 1.89 P82198
SB135 (MYADM OR MUG) 2.01 O35682
Green indicates a 1.7 fold downregulation of a certain gene in comparison to the control 
sample, while red indicates a more than 1.7 fold increase of the respective gene in 
comparison to the control. T2 cells are the control and T1 cells are the experiment. 
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Contrary to the data obtained from Affymetrix, none of the NF-κB or related genes was 
differentially expressed between T1, T2 and mature B cells. 
In addition to known BCR signaling and apoptosis related genes  I also analyzed 
data of genes known to play a roles in immunological responses. Tables 5 and 6 list 
genes that were either upregulated or downregulated 1.7 fold. Green indicates a 1.7 fold 
downregulation of a certain gene in comparison to the control sample, while red 
indicates a more than 1.7 fold increase of the respective gene in comparison to the 
control. These genes may lead to previously unstudied pathways and molecules that 
may play a role in transitional B cell survival and differentiation. 
 
Discussion 
In studies presented here, two different platforms of microarray analysis were 
employed. A whole genome analysis utilized the Affymetrix Mouse 2.0 arrays. This array 
provides coverage of the transcribed mouse genome on a single array, including 39,000 
transcripts, representing, 34,000 well characterized mouse genes. In addition I also used 
a new platform from Miltenyi Biotec laboratories, which uses a topic-defined array, in 
order to focus the analysis. These platforms were used to characterize the genetic 
architecture of each differentiating B cell population which is likely to contribute to the 
specific biochemical code at each development stage and may control distinct cellular 
responses. To simplify the analysis, I focused our attention on the regulation of genes 
involved in BCR signaling, survival and the genes responsible for regulating the 
transcription of these survival genes, with a focus on the NF-κB pathway. 
In both the Affymetrix and PIQOR microarray analyses, known BCR molecules 
were not differentially expressed in any B cell subset. This is most likely due because 
the membrane proximal signaling events in BCR signaling are important in the  
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Gene Fold Accesion
MAPK11 (P38 BETA) 2.06 Q9WUI1
TNFRSF9 (CD137 ANTIGEN). 4.3 P20334
TNFRSF11A (RANK) (RECEPTOR ACTIVATOR OF NF-KB) 4.35 Q8VCT7
CD62L (LY-22) 1.79 P18337
THY1 (CD90) 4.35 P01831
CD23 1.86 P20693
ITGA4 (INTEGRIN ALPHA-IV)(CD49D) 2.02 Q61740
CD5 5.88 P13379
GPCR25 1.78 Q921N3
KIAA0042: (KIAA0042 OR KIF14) KINESIN-LIKE PROTEIN KIF14. 2.44 O35064
BMP-8 (OP 2). 2.38 P34821
CYR61 (IGFBP10 OR GIG1 OR CCN1) 2.7 P18406
TGF-BETA 3 2.32 P17125
GREM2 2.38 O88273
DOC2 BETA. 2.32 Q6NXK3
UBIQUITIN-PROTEIN LIGASE NEDD-4 3.57 O08758 
NEDD-4-LIKE E3 UBIQUITIN-PROTEIN LIGASE WWP2 2 Q8BTG4
APXL 2.32 Q8CDZ0
MPP2 (MAGUK P55 SUBFAMILY MEMBER 2) 2.63 Q9WV34
(PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1) 1.75 P62259
FAK1: (FAK1 OR FAK OR PTK2) 2.5 P34152 
HCK 1.81 P08103
PTPN12: (PROTEIN-TYROSINE PHOSPHATASE G1) 1.92 P35831
CCR6 (CCR6 OR CMKBR6 OR STRL22 OR GPR29 OR CKRL3) 3.68 O54689
CCR8: (CCR8 OR CMKBR8 OR CKRL1 OR TER1) 2.27 P56484
STMN1 (STMN1 OR LAP18 OR OP18) 2.56 P54227
COL9A2(ALPHA-2 IX COLLAGEN) 2.5 Q07643
ITGB7 (INTEGRINB7) 2.15 P26011
LAMB1 (LAMININ B1 CHAIN) 1.92 P02469
FOSB (G0/G1 SWITCH REGULATORY PROTEIN 3). 3.03 P13346
C-FOS) 2.12 P01101
FOXG1A-FOXG1B (TRANSCRIPTION FACTOR BF-2). 1.96 Q80VP3 
FIP (FOS-INTERACTING PROTEIN) 2.22 Q64705
SMALL INDUCIBLE CYTOKINE A17 2.5 Q9WUZ6
CD118 (IFN-ALPHA-REC) 2.04 P33896
GRL (GRL OR NR3C1) 2.17 P06537
TRAF1 2.32 P39428
C-MYB 7.14 P06876
SMAD5 2.38 P97454
MGST2 (GST2) 3.45 Q8R032
AOC3 (VAP1) 2.27 O70423
DR6 (TNFRSF21) 2.27 Q91XH9
FCP1 (CTDP1) 2 Q7TSG2 
HHEX (PRHX OR PRH OR HEX) 2 P43120
IRAK-M (IRAK3) 1.78 Q8CE40
LMO-4 1.75 P61969
RGS2 (G0/G1 SWITCH REGULATORY PROTEIN 8). 3.85 O08849 
CD44 2.04 Q05732 
AIF1 (IBA1) 1.72 Q9EQW9
CAPN2 (CAPN2) 2.04 O35518 
KLF6: (COPEB OR BCD1 OR CPBP) 1.81 -
TLR-3 1.87 Q99MB1 
Table 6. List of genes differentially expresses in freshly isolated T2 and 
mature B cells from the PIQOR microarrays.           
Green indicates a 1.7 fold downregulation of a certain gene in comparison to the control 
sample, while red indicates a more than 1.7 fold increase of the respective gene in 
comparison to the control. T2 cells are the control and mature cells are the experiment. 
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maintenance and survival of immature and mature B cells. It is unlikely that these genes 
would vary significantly between T1, T2 and mature B cell. 
There are many families of anti- and pro-apoptotic genes. One of the better 
characterized is the Bcl-2 family. Bcl-2-related proteins can act as cellular bodyguards or 
assassins to positively or negatively control apoptosis (55). Bcl-2 family proteins are 
characterized by the presence of up to four relatively short sequence termed Bcl-2 
homology (BH) domains. More than 20 family members have been identified and these 
can be divided into three subfamilies, based on structural and functional features. The 
anti-apoptotic subfamily contains the Bcl-2 and Bcl-XL proteins, which suppress 
apoptosis and contain all four BH domains, designated BH1–4. Mcl-1 is another Bcl-2-
related survival protein, but is somewhat structurally distinct and lacks a BH4 domain. 
Pro-apoptotic proteins, such as Bax and Bak contain BH1–3 domains and are termed 
'multidomains', whereas other pro-apoptotic proteins, such as Bim, Bad and Bid, contain 
only the BH3 domain and are termed 'BH3-only'. The targeting of Bcl-2 family proteins to 
mitochondrial membranes is thought to play an important role in apoptotic cell death (55). 
The relative expression and activity of various anti-apoptotic and pro-apoptotic 
Bcl-2 family proteins is a critical determinant of apoptosis sensitivity. Precisely how the 
functions of the separate subfamilies and individual Bcl-2 proteins are coordinated to 
control apoptosis is unclear. I performed microarray analysis on non-stimulated and BCR 
stimulated T1, T2 and mature B cells. Upon examination of the survival genes that 
showed at least a 2 fold difference, I found that T1 cells had consistently lower levels of 
anti-apoptotic genes, when compared to T2 and mature B cells, both in non-stimulated 
and stimulated samples. Of these genes, A1 and Bcl-2 were of particular interest due to 
their role in B cell survival and these genes are currently being studied in our lab. A1 
was found to be 6.5 fold lower in non-stimulated T1 when compared to T2, and 5.28 fold 
less than non-stimulated mature B cells. After 1 hour stimulations with anti-IgM, T1 cells 
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still had significant lower levels of A1, 3.5-27.86 as compared to T2 cells and 6.5 when 
compared to mature B cells. Bcl-2 showed an almost identical trend as A1. Inspection of 
the pro-apoptotic genes revealed no significant difference between T1, T2 and mature B 
cell subsets; therefore they are not shown in table 2.  
Interestingly, upon examination of number of genes that are different between T1, 
T2, and mature B cells, I observed that non-stimulated mature B cells had more genes 
expressed at higher levels, than T1 or T2 B cells. This difference decreases upon 
stimulation. This suggests that in non-stimulated B cells, mature cells have a higher 
relative expression of both anti- and pro-apoptotic genes, than T1 and T2 B cells. The 
decrease after stimulation could imply that T1 and T2 B cells upregulate many of these 
survival genes to similar levels as mature B cells. On the other hand, this could also 
mean, that mature B cells, downregulate the relative expression of these genes after 
BCR engagement.  In response to BCR stimulation all three subsets were capable of 
down- and up-regulating both anti- and pro-apoptotic genes to the same extent. In 
addition, there was no significant difference in the number of genes that were identified 
as altered in each transitional and mature B cell subset. 
The relative expression of NF-κB subunits, as well as its upstream regulators 
inhibitors of κB (IκBs), and inhibitors of κB kinase (IKKs) revealed significant differences 
in the levels of only some genes in the NF-κB pathway. The most appreciable difference 
was that non-stimulated T1 cells had lower levels of NF-κB1 (p105/p50) and NF-κB2 
(p100/p52) when compared to both T2 and mature B cells. NF-κB1 is important in 
controlling lymphocyte and macrophage function in immune and inflammatory responses. 
NF-κB1 deficient mice have impaired B cell proliferation (56). Interestingly I found that 
most of these genes were consistently higher in non-stimulated mature cells, when 
compared to both T1 and T2 cells, but that these differences are not observed after one 
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hour stimulations. This suggest that both T1 and T2 B cells are both capable of 
upregulating these genes at similar levels to mature B cells, or that after 1 hour 
stimulations, mature cells, downregulate these genes to the same level as T1 and T2 B 
cells. This observation is similar to that of the survival genes (Table 2). Additionally, a 
lower expression of NF-κB1 and NF-κB2 in T1 relative to T2 and mature B cells 
correlates well with the observed lower expression of survival genes in this B cell subset 
and suggest that these differences may mediate sensitivity of T1 B cells to apoptosis. 
To address the in vivo significance of our gene expression profiling, I performed 
additional microarray analysis of freshly isolated T1, T2 and mature B cells using an 
immunology topic defined microarray (Miltenyi Biotec). This array contains over a 
thousand genes that represent genes for immune response, cell death, extracellular 
matrix, and signal transduction. Initially I focused our analysis on survival genes, as I did 
previously with the Affymetrix microarray. I found that most survival genes were not 
differentially expressed within T1, T2 and mature B cells. Consistent with previous 
experiments closer examination revealed that A1 and Bcl-2 were expressed at lower 
levels (2 fold) in T1 when compared with T2 (Table5, highlighted) and mature B cells. As 
previously mentioned, pro-apoptotic genes showed no difference among T1, T2 and 
mature B cells. These data, in addition to the results from the Affymetrix microarray, 
support the idea that it is the levels of anti-apoptotic genes, may contribute to the 
differential responses seen in T1 and T2 B cells upon BCR crosslinking. 
 Analysis of the NF-κB genes in the PIQOR array revealed that there was no 
difference in the level of NF-κB1 or NF-κB2. These results are contradictory to those 
obtained in the Affymetrix array. Our lab has studied through the use of Real Time PCR 
(TaqMan) that T1 cells do have lower levels of both NF-κB1 and NF-κB2 compared to 
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T2 and mature B cells. This suggests that the PIQOR microarray is possibly less 
sensitive in detecting changes in the levels of transcripts.  
There are a number of signaling pathways other than survival genes that likely 
play a role in the survival and differentiation of immature B cells. These signals could be 
derived from other cell surface receptors involved in any number of cellular events, 
ranging from integrin signaling, Toll-like receptors and chemokine receptors among 
many others. The previous analyses of BCR stimulated T1, T2 and mature B cells, 
allows us to elucidate those genes that are affected by BCR signaling. Studies 
performed with freshly isolated cells provide information of the signaling events including 
those (independent of BCR signaling) in vivo. The genes that were identified in tables 5 
and 6 represent genes involved in other cellular events.  
Together, these studies provide a molecular basis for understanding the stage-
specific genetic programs and signaling pathways that regulate B cell responses of cell 
death versus survival, proliferation and differentiation. 
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CHAPTER IV 
 
CONCLUDING REMARKS 
 
The immature B cell compartment in the spleen comprises of two subsets termed 
Transitional Type 1 (T1) and Transitional Type 2 (T2). Our laboratory has shown that T1 
and T2 B cell subsets respond differently to crosslinking of the BCR; T1 cells die upon 
BCR stimulation whereas T2 cells proliferate and differentiate into a mature B cell 
phenotype. The signaling mechanisms that control these disparate biological outcomes 
in T1 versus T2 cells remain elusive. I employed genomic and proteomic approaches to 
define the global genetic programs and biochemical signaling programs that control the 
differential BCR responses of T1, T2 and mature B cells. 
Through proteomics I identified SKAP55 in lipid rafts from BCR stimulated T1 
cells, and RNA and protein analysis verified its preferential expression in T1 cells (Figs. 
9). I also identified CD45-AP specifically in lipid rafts from stimulated T1 cells. In this 
regard, I have found that like CD45-deficient mice, CD45-AP-deficient mice also have an 
increase in transitional B cells suggesting a defect in BCR-induced cell death and 
negative selection (Fig. 8). Previous studies have shown a link between SKAP55 and 
CD45 in T cells, and their role in T cell receptor signaling. Prior studies have also shown 
that SKAP55 is able to bind various Src-kinases, including Lyn. Together these data 
suggest that SKAP55 may couple CD45/CD45-AP to BCR signaling through its 
interaction with Lyn. This proximity may concentrate CD45 activity on the negative 
regulatory tyrosine (Y508) enhancing Lyn activity. In future experiments we will 
investigate this hypothesis by immunoblotting with site-specific phosphorylation Abs to 
Lyn in CD45-AP-/- in comparison with skap55-/- T1 B cells. Currently skap55-/- mouse is 
not available, but our lab is planning to generate this knockout strain. To determine 
 53 
whether SKAP55 gene deletion affects B cell maturation, we will employ in-depth 
flowcytometry (FCM) analysis to characterize B cell subsets. Additionally, skap55-/- BM 
cells would be transferred into sublethally irradiated wt mice and cells would be 
recovered and analyzed each week for 6-8 weeks for FCM analysis for B cell 
developmental phenotype to determine whether any observed defects in skap55-/- mice 
are B cell intrinsic 
 I also hypothesize that SKAP55 may regulate BCR signaling as shown previously 
in T cells.  To test this hypothesis we will assess the effects of SKAP55 deletion on BCR 
signal-dependent responses of T1 relative to other B cell subsets. I anticipate that loss of 
SKAP55 will affect peripheral B cell maturation at the T1 stage due to its selective 
expression in this B cell subset (Fig. 9). In Addition if we find a defect in cell survival we 
will define the underlying molecular mechanisms by assaying for the induction of anti-
apoptotic proteins such as A1, Bcl-2, and Bcl-XL. The roles of these anti-apoptotic genes 
in B cell survival are currently being studied in our lab. 
 It is critical to investigate SKAP55 and CD45/CD45-AP interactions in T1 specific 
signaling pathways as well as the impact of SKAP55 in the regulation of T1 B cell 
development. This question can be addressed by comparing the phenotype of skap55-/- 
mice with CD45-AP-/- or CD45-/- mice. If we find similar B cell defects in these knockout 
models, these experiments would suggest a functional link between SKAP55 and 
CD45/CD45-AP during B cell development and would be followed up by interbreeding of 
skap55-/- mice with CD45-AP-/- or CD45-/- mice. We would employ in-depth flowcytometry 
(FCM) analysis to characterize any defect in development and B cell subsets. 
Migration of T1 cells into B cell follicles coincides with their transition into T2 cells.  
The mechanisms that control T1 cell adhesion and migrations are unclear.  A recent 
report demonstrated that SKAP55 could increase T cell-APC conjugation, adhesion to 
fibronectin and intercellular adhesion molecule-1 (ICAM-1), and enhances integrin- 
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adhesion. These results suggest that SKAP55 may facilitate T1 migration into B cell 
follicles.  Therefore, it would be important to investigate whether localization of B cell 
subsets is altered in the skap55-/- mice. If an alteration in the localization of B cell 
subsets in skap55-/- mice is observed, the effects of SKAP55 deficiency on T1 cell 
adhesion and migration could be assessed.  
I used two different microarray platforms to characterize the genetic architecture 
of each B cell population as a way to define the biochemical signals that may play a role 
in their distinct biological outcomes. I focused our analysis on survival genes, anti- and 
pro-apoptotic, and genes that regulate the transcription of these survival genes. These 
analyses showed that levels of pro-apoptotic genes did not vary between T1, T2 and 
mature B cells. In freshly isolated and cultured cells that were un-stimulated and 
stimulated, I consistently found that A1 and Bcl-2 were expressed in lower levels in T1, 
than in T2 and mature B cells. These data suggest that it is a quantitative difference of 
these survival genes that may lead to the disparate outcomes seen in T1 and T2 B cells. 
 Even though microarrays offer a powerful approach to the analysis of gene 
expression many of the genes we focused on are regulated post-translationaly. These 
microarray studies allow us to identify candidate genes that may play an essential role in 
the survival and differentiation of transitional and mature B cells. Our lab is currently 
working on characterizing, at a stage specific level, the protein levels of these and other 
anti-apoptotic genes. In addition, we are studying the signals that are required for the 
transcription of these genes. These studies will establish the contribution of these 
survival genes in the development of T1, T2 and mature B cells. 
These studies also revealed differential expression other genes involved in 
multiple signaling pathways. These genes may lead to previously unthought of pathways 
that may play a role in development and differentiation of T1 and T2 B cells. 
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Together, these studies provide a molecular basis for understanding the stage-
specific signaling pathways that regulate B cell responses in T1, T2 and mature B cells. 
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